FDA Plan to Combat Opioid Epidemic Highlights AJPB Week in Review

Article

Top articles of the week from The American Journal of Pharmacy Benefits.

5. Brain Glucose Levels Drop in Patients with Obesity, Diabetes

Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes. Read more.

4. FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma

Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth. Read more.

3. CVS Launches New Performance-Based PBM Network

New network encourages medication adherence for chronic conditions. Read more.

2. Novartis Seeks New Indication for Gene Therapy Kymriah

Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma. Read more.

1. FDA Highlights New Strategies to Combat the Opioid Epidemic

Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic. Read more.

Related Videos
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
Ozempic, obesity, drug shortage, media portrayal | Image Credit: zimmytws - stock.adobe.com
Collaborative Care Team for Diabetes, Cardiovascular Disease | Image Credit: Production Perig - stock.adobe.com
Pharmacist helping patient use glucose monitor -- Image credit: Kalyakan | stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Cholesterol diet and healthy food eating nutritional concept with clean fruits in nutritionist's heart dish and patient's blood sugar control record with diabetic measuring tool | Image Credit: Chinnapong - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.